Director received an award of 15K GMED derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jan 21, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jan 23, 2026
DirectorGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001193125-26-021195
- Filed / recorded
Added to OQROOct 6, 2026, 7:37 PM UTC Data qualityVerified: identifiers matched exactly Reporting personJohn A Deford SecurityStock Option (Right to Buy Class A Common Stock) TableDerivative (Table II) Transaction dateJan 21, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- These options were granted on January 21, 2026, and will vest on January 1, 2027.
Around the same time
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$877K of Globus Medical
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.